News
MRFF backs UQ epilepsy research
17 September 2024
UQ researchers have received $4.1 million from the Medical Research Future Fund to advance their research into epilepsy treatments made from spider venom proteins.
Led by Professor Ernst Wolvetang, the project aims to prove the safety and efficacy of venom-based drugs by testing them on lab-grown brain and heart organoids grown from the cells of epilepsy patients.
The research aims to pave the way for human clinical trials and to establish organoids as a tool that can be used to test experimental treatments and therapies.
The funding has been provided through the MRFF’s Stem Cell Therapies grant scheme.
Media contactUQ Communications
communications@uq.edu.au
+61 429 056 139
Related articles
Feature
The Paralympian paving the way for more champions in the pool
As Paralympic swimmer Rachael Watson eyes a third gold medal in Los Angeles in 2028, the UQ student is determined to create new pathways for future champions.
18 November 2026
UQ strengthens Indigenous partnership in New Zealand
The University of Queensland and the Waipapa Taumata Rau, University of Auckland have strengthened their long-standing relationship through the signing of a new International Cooperation Agreement.
17 November 2026
Media contact
UQ Communications
communications@uq.edu.au
+61 429 056 139
Subscribe to UQ News
Get the latest from our newsroom.